170 related articles for article (PubMed ID: 37737023)
1. Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors.
Baskaran AB; Bhatia A; Kumthekar P; Boire A; Lukas RV
Future Oncol; 2023 Aug; 19(26):1801-1807. PubMed ID: 37737023
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.
Lazaratos AM; Maritan SM; Quaiattini A; Darlix A; Ratosa I; Ferraro E; Griguolo G; Guarneri V; Pellerino A; Hofer S; Jacot W; Stemmler HJ; van den Broek MPH; Dobnikar N; Panet F; Lahijanian Z; Morikawa A; Seidman AD; Soffietti R; Panasci L; Petrecca K; Rose AAN; Bouganim N; Dankner M
Breast; 2023 Jun; 69():451-468. PubMed ID: 37156650
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
5. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
6. 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
Mason WP; Yeh SD; DeAngelis LM
Neurology; 1998 Feb; 50(2):438-44. PubMed ID: 9484369
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal metastases from solid tumors (meningeal carcinomatosis).
Bruno MK; Raizer J
Cancer Treat Res; 2005; 125():31-52. PubMed ID: 16211882
[TBL] [Abstract][Full Text] [Related]
8. A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers.
Jafari F; Nodeh MM; Hosseinjani H; Baharara H; Azad S; Arasteh O; Johnston TP; Sahebkar A
Curr Med Chem; 2024; 31(19):2732-2750. PubMed ID: 37157199
[TBL] [Abstract][Full Text] [Related]
9. 111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik P; Jaeckle KA; Glantz M
Neurology; 1999 Jan; 52(1):216-7. PubMed ID: 9921888
[No Abstract] [Full Text] [Related]
10. [Use of Ommaya Reservoirs to Deliver Pemetrexed in Leptomeningeal Metastasis from Non-small Cell Lung Cancer: A Case Report and Review of the Literature].
Lin Y; Li H; Huang M; Guo A; Yin Z
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):546-550. PubMed ID: 31451148
[TBL] [Abstract][Full Text] [Related]
11. Therapy of leptomeningeal metastasis in solid tumors.
Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal thiotepa: reappraisal of an established therapy.
Fisher PG; Kadan-Lottick NS; Korones DN
J Pediatr Hematol Oncol; 2002 May; 24(4):274-8. PubMed ID: 11972095
[TBL] [Abstract][Full Text] [Related]
13. Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis.
Nakagawa H; Yui Y; Sasagawa S; Itoh K
J Neurooncol; 2018 Aug; 139(1):43-50. PubMed ID: 29626288
[TBL] [Abstract][Full Text] [Related]
14. [Spinal metastases combined with leptomeningeal metastasis: A case report].
Ma LJ; Hu PP; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):563-566. PubMed ID: 37291936
[TBL] [Abstract][Full Text] [Related]
15. Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab.
Kordbacheh T; Law WY; Smith IE
Breast; 2016 Apr; 26():54-8. PubMed ID: 27017242
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
Lin Y; Yu T; Li H; Yin Z; Guo A
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy.
Bokstein F; Lossos A; Siegal T
Cancer; 1998 May; 82(9):1756-63. PubMed ID: 9576299
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
Chen TW; Jan IS; Chang DY; Lin CH; Chen IC; Chen HM; Cheng AL; Lu YS
J Neurooncol; 2020 May; 148(1):165-172. PubMed ID: 32346837
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of the leptomeningeal metastases related to solid tumors].
Le Rhun E; Zairi F
Bull Cancer; 2013; 100(7-8):765-74. PubMed ID: 23747742
[TBL] [Abstract][Full Text] [Related]
20. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Glantz MJ
Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]